期刊文献+

Relationship between the Expression of Vascular Endothelial Growth Factor C and Lymphangiogenesis in Human Pancreatic Cancer

胰腺癌VEGF-C的表达与淋巴管生成的关系及意义(英文)
下载PDF
导出
摘要 Objective: To investigate the role the vascular endothelial growth factor C (VEGF-C) expression in lymphangiogenesis and lymph node metastasis in pancreatic cancer. Methods: The expression of VEGF-C in pancreatic cancer tissue of 42 cases and normal pancreatic tissue of 10 cases was detected by using immunohistochemical S-P method. The microlymphatic vessel density (MLVD) of both tissues was measured by enzyme-histochemical method at the same time. Results: The VEGF-C positive expression rate was significantly higher in pancreatic cancer tissue (64.3%) than in normal pancreatic tissue (20%, P〈0.05). The MLVD was significantly higher in pancreatic cancer tissue (21.93±6.39) than that in normal pancreatic tissue (4.40±2.07, P〈0.001). The VEGF-C positive expression rate, MLVD and lymph node metastasis had a positive correlation. Conclusion: The VEGF-C may play an important role in the lymphangiogenesis and lymph node metastasis of pancreatic cancer.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2006年第2期96-98,共3页 中德临床肿瘤学杂志(英文版)
关键词 lvascular endothelial growth factor C LYMPHANGIOGENESIS lymph node metastasis microlymphatic vessel density 血管内皮生长因子C 胰腺癌 治疗 病理机制
  • 相关文献

参考文献2

二级参考文献42

  • 1Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis- correlation in invasive breast carcinoma[J]. N Engl J Med. 1991.324(1): 1 -8.
  • 2Kitamura K, Yamaguchi T, Taniguchi H, et al. Analysis of lymph node metastasis in early gastric cancer: rationale of imitated surgery [ J ]. J Surg Onclo, 1997,64 ( 1 ): 42 - 49.
  • 3Kaipainen A, Korhoren J, Taipale J, et al. Expression of the fins-like tyrosine kinase FLT-4 gene becomes restricted to endothelium of lymphatic vessels during development[J] . Proc Natl Acad Sci USA, 1995, 92(8): 3566- 3570.
  • 4Fisher ER. Detection and significance of occult axillary node metastasis in patients with invasive breast cancer[J]. Cancer,1978, 42: 2025.
  • 5Joukov V, Pajusola K, Kaipainen A, et al. A novel Vasculax endothelial growth factor, VEGF-C, is a ligand for the FLT4(VEGFR-3) and KDR(VEGFR-2) receptor tyrosine jinases[J] .EMBO J, 1996,15 (2): 290 - 298.
  • 6Jian-Feng Wang. Ganju RK, Zhong-Ying Liu, et al. Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor[J]. Blood, 1997,90(9): 3507 - 3515.
  • 7Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues[J] .FASEB J, 2000, 14( 13): 2087 - 2097.
  • 8Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis[J]. British J Cancer, 1999,80(1/2): 309 - 313.
  • 9Kitadai Y, Amioka T, Haruma K, et al. Clinicopatholagical significance of vascular endothelial growth factor (VEGF) -C in human esophageal squamous cell carcinomas[J] . Int J Cancer,2001, 93(5): 662 - 666.
  • 10Dumont DJ, Jussila L, Taipale J, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor 3[J]. Science, 1998,282 (5390): 946 - 949.

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部